Mitchell MS - Search Results

1

Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.

Kan-Mitchell J, Liggett PE, Harel W, Steinman L, Nitta T, Oksenberg JR, Posner MR, Mitchell MS. Kan-Mitchell J, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1991;33(5):333-40. doi: 10.1007/BF01756599. Cancer Immunol Immunother. 1991. PMID: 1831067 Free PMC article.

2

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau HY, Lind S. Mitchell MS, et al. Cancer Res. 1988 Oct 15;48(20):5883-93. Cancer Res. 1988. PMID: 3262416

3

Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.

LeMay LG, Kan-Mitchell J, Goedegebuure P, Harel W, Mitchell MS. LeMay LG, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1993 Aug;37(3):187-94. doi: 10.1007/BF01525434. Cancer Immunol Immunother. 1993. PMID: 8101473 Free PMC article.

4

Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Huang XQ, Mitchell MS, Liggett PE, Murphree AL, Kan-Mitchell J. Huang XQ, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1994 Jun;38(6):399-405. doi: 10.1007/BF01517210. Cancer Immunol Immunother. 1994. PMID: 8205561 Free PMC article.

5

Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action.

Mitchell MS, Harel W, Kan-Mitchell J, LeMay LG, Goedegebuure P, Huang XQ, Hofman F, Groshen S. Mitchell MS, et al. Ann N Y Acad Sci. 1993 Aug 12;690:153-66. doi: 10.1111/j.1749-6632.1993.tb44005.x. Ann N Y Acad Sci. 1993. PMID: 8368734 Clinical Trial.

6

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.

Kan-Mitchell J, Huang XQ, Steinman L, Oksenberg JR, Harel W, Parker JW, Goedegebuure PS, Darrow TL, Mitchell MS. Kan-Mitchell J, et al. Among authors: mitchell ms. Cancer Immunol Immunother. 1993 Jul;37(1):15-25. doi: 10.1007/BF01516937. Cancer Immunol Immunother. 1993. PMID: 8513449 Free PMC article.

7

Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.

Kan-Mitchell J, White WL, Mitchell MS. Kan-Mitchell J, et al. Among authors: mitchell ms. Cancer Res. 1989 Aug 15;49(16):4536-41. Cancer Res. 1989. PMID: 2472881

8

Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes.

Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Kan-Mitchell J, et al. Among authors: mitchell ms. Invest Ophthalmol Vis Sci. 1989 May;30(5):829-34. Invest Ophthalmol Vis Sci. 1989. PMID: 2722439

9

Association of HLA phenotype with response to active specific immunotherapy of melanoma.

Mitchell MS, Harel W, Groshen S. Mitchell MS, et al. J Clin Oncol. 1992 Jul;10(7):1158-64. doi: 10.1200/JCO.1992.10.7.1158. J Clin Oncol. 1992. PMID: 1607920

10

Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccine.

Mitchell MS, Liggett PE, Green RL, Kan-Mitchell J, Murphree AL, Dean G, Spears L, Walonker F. Mitchell MS, et al. J Clin Oncol. 1994 Feb;12(2):396-401. doi: 10.1200/JCO.1994.12.2.396. J Clin Oncol. 1994. PMID: 8113847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters